Conference Description
Key Takeaways
- Dual-track event combining brand and IP protection with pharmaceutical anti-counterfeiting and serialization
- Covers DSCSA compliance, track-and-trace technology, blockchain applications, and cold chain security
- Designed for pharmaceutical executives, legal and IP professionals, compliance officers, and supply chain managers
- Features participation from regulatory bodies including DEA, FDA, CBP, and USPTO
- In-person format with panel discussions, workshops, roundtables, and solution showcases
About the Event
The 2026 Collocated Summit Series in Washington DC brings together two established conferences: the Brand & IP Protection Summit and the 18th Pharma Anti-Counterfeiting, Serialization & Supply Chain Security Conference. The dual-track structure allows attendees to move between sessions addressing intellectual property enforcement and pharmaceutical supply chain integrity.
The event draws global industry leaders, legal experts, regulators, and pharmaceutical executives. Government participation includes representatives from the Drug Enforcement Administration, Food and Drug Administration, Customs and Border Protection, and United States Patent and Trademark Office.
Anti-Counterfeiting and Serialization Focus
The pharmaceutical track addresses counterfeit drug prevention through forensic detection methods, serialization requirements, and track-and-trace technology implementation. Sessions examine packaging innovations designed to authenticate products throughout the distribution chain. Cold chain security receives dedicated attention given the temperature sensitivity of many pharmaceutical products.
Technology discussions cover blockchain applications for supply chain transparency and digital authentication systems. These tools support compliance with the Drug Supply Chain Security Act (DSCSA), which mandates electronic tracking of prescription drugs through the U.S. distribution system.
Brand and Intellectual Property Protection
The brand protection track examines global IP legal frameworks, licensing strategies, and enforcement mechanisms. Digital piracy and online brand infringement present growing challenges as counterfeiters exploit e-commerce platforms. Sessions address both legal remedies and technical countermeasures for protecting brand reputation across digital channels.
Who Should Attend
The conference targets senior leaders and technical experts from pharmaceutical, biotech, healthcare, legal, and technology sectors. Specific roles include pharmaceutical executives, brand owners, IP attorneys, compliance officers, supply chain and logistics managers, and regulatory affairs specialists. Technology providers and consultants serving these industries will find relevant content and networking opportunities.
Event Format
The in-person event features panel discussions, hands-on workshops, collaborative roundtables, networking receptions, and solution showcases from technology providers. Sponsors and partners include Ten Count Consulting, SICPA, D2 Solutions, Indegene, Pantherx Rare Pharmacy, Arriello, 4C Pharma, Vitrana, RxLogix, Hogan Lovells, and Navatio Pharma.